4.7 Article

Impact of Different Antimicrobial Therapies on Clinical and Fiscal Outcomes of Patients with Bacteremia Due to Vancomycin-Resistant Enterococci

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Vancomycin-resistant Enterococcus bacteremia: An evaluation of treatment with linezolid or daptomycin

Jennifer D. Twilla et al.

JOURNAL OF HOSPITAL MEDICINE (2012)

Editorial Material Public, Environmental & Occupational Health

Growing Prevalence of Vancomycin-Resistant Enterococcus faecalis in the Region with the Highest Prevalence of Vancomycin-Resistant Staphylococcus aureus

Kayoko Hayakawa et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)

Article Infectious Diseases

Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?

Esther A. King et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)

Article Infectious Diseases

Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?

Vidya Mave et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)

Article Public, Environmental & Occupational Health

CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting

Teresa C. Horan et al.

AMERICAN JOURNAL OF INFECTION CONTROL (2008)

Review Critical Care Medicine

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

R. Phillip Dellinger et al.

CRITICAL CARE MEDICINE (2008)

Review Infectious Diseases

Emergence and management of drug-resistant enterococcal infections

Cesar A. Arias et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)

Article Public, Environmental & Occupational Health

Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs

XY Song et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)